Suzuki, Takeshi

• Journal of Regulatory Science Vol. 8 (2020) - Review Articles
  Japanese Pharmaceutical Industry: Recent Perspectives and Areas for Further Research
  Abstract  PDF
• Journal of Regulatory Science Vol. 4 No. 1 (2016) - Scientific Articles
  A Comprehensive Analysis of Factors That Contribute to Conditional Approval and All-Case Surveillance Designations That Subsequently Lead to Shortening of Review Times in Japan
  Abstract  PDF  Figures 1-4　(PDF file)
• Journal of Regulatory Science Vol. 4 No. 3 (2016) - Scientific Articles
  Emerging Growth of Orphan Drugs for Neurological Diseases in Japan: Potential Benefits for Both Patients and Pharmaceutical Companies
  Abstract  PDF  Figure 1  Figure 2  Figure 3
• Journal of Regulatory Science Vol 7 (2019) - Scientific Articles
  Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor
  Abstract  PDF